skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Biomarkers for lymphoma

Abstract

A biomarker, method, test kit, and diagnostic system for detecting the presence of lymphoma in a person are disclosed. The lymphoma may be Hodgkin's lymphoma or non-Hodgkin's lymphoma. The person may be a high-risk subject. In one embodiment, a plasma sample from a person is obtained. The level of at least one protein listed in Table S3 in the plasma sample is measured. The level of at least one protein in the plasma sample is compared with the level in a normal or healthy subject. The lymphoma is diagnosed based upon the level of the at least one protein in the plasma sample in comparison to the normal or healthy level.

Inventors:
;
Issue Date:
Research Org.:
Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1154935
Patent Number(s):
8,822,164
Application Number:
13/690,073
Assignee:
Battelle Memorial Institute (Richland, WA)
DOE Contract Number:  
AC05-76RLO1830
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Zangar, Richard C., and Varnum, Susan M. Biomarkers for lymphoma. United States: N. p., 2014. Web.
Zangar, Richard C., & Varnum, Susan M. Biomarkers for lymphoma. United States.
Zangar, Richard C., and Varnum, Susan M. Tue . "Biomarkers for lymphoma". United States. https://www.osti.gov/servlets/purl/1154935.
@article{osti_1154935,
title = {Biomarkers for lymphoma},
author = {Zangar, Richard C. and Varnum, Susan M.},
abstractNote = {A biomarker, method, test kit, and diagnostic system for detecting the presence of lymphoma in a person are disclosed. The lymphoma may be Hodgkin's lymphoma or non-Hodgkin's lymphoma. The person may be a high-risk subject. In one embodiment, a plasma sample from a person is obtained. The level of at least one protein listed in Table S3 in the plasma sample is measured. The level of at least one protein in the plasma sample is compared with the level in a normal or healthy subject. The lymphoma is diagnosed based upon the level of the at least one protein in the plasma sample in comparison to the normal or healthy level.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2014},
month = {9}
}

Patent:

Save / Share:

Works referenced in this record:

Plasma Proteome Response to Severe Burn Injury Revealed by 18 O-Labeled “Universal” Reference-Based Quantitative Proteomics
journal, September 2010

  • Qian, Wei-Jun; Petritis, Brianne O.; Kaushal, Amit
  • Journal of Proteome Research, Vol. 9, Issue 9
  • DOI: 10.1021/pr1005026

Plasma Biomarkers for Detecting Hodgkin's Lymphoma in HIV Patients
journal, December 2011


Multiplexed protein measurement: technologies and applications of protein and antibody arrays
journal, March 2006

  • Kingsmore, Stephen F.
  • Nature Reviews Drug Discovery, Vol. 5, Issue 4
  • DOI: 10.1038/nrd2006

Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma
journal, March 2011